| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 672035 | 70071 | CAPENON 40 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CAPENON 40 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70071/70071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70071/70071_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2008-09-16 | 1 | 1 | 1 | 2008-09-16 | 2011-05-11 | 1 | 2011-10-28 | 661491 | View Edit Delete | |||||||||||
| 674878 | 72693 | OPENVAS PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72693/72693_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72693/72693_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2010-10-05 | 1 | 1 | 1 | 2010-10-05 | 2010-10-05 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 674883 | 72694 | OPENVAS PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72694/72694_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72694/72694_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2010-10-05 | 1 | 1 | 1 | 2010-10-05 | 2010-10-05 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 674888 | 72695 | OLMETEC PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OLMETEC PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72695/72695_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72695/72695_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2010-10-05 | 1 | 1 | 1 | 2010-10-05 | 2010-10-05 | 1 | 2011-05-26 | View Edit Delete | ||||||||||||
| 674892 | 72697 | OLMETEC PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OLMETEC PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72697/72697_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72697/72697_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2010-10-05 | 1 | 1 | 1 | 2010-10-05 | 2010-10-05 | 1 | 2011-05-26 | View Edit Delete | ||||||||||||
| 672811 | 73022 | VALSARTAN/HIDROCLOROTIAZIDA PENSA 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA PENSA 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73022/73022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73022/73022_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2010-11-18 | 1 | 1 | 1 | 2010-11-18 | 2010-11-18 | 1 | 2019-07-31 | View Edit Delete | ||||||||||||
| 672812 | 73020 | VALSARTAN/HIDROCLOROTIAZIDA PENSA 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA PENSA 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73020/73020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73020/73020_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2010-11-17 | 1 | 1 | 1 | 2010-11-17 | 2010-11-17 | 1 | 2019-07-31 | View Edit Delete | ||||||||||||
| 672813 | 73021 | VALSARTAN/HIDROCLOROTIAZIDA PENSA 160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA PENSA 160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73021/73021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73021/73021_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2010-11-17 | 1 | 1 | 1 | 2010-11-17 | 2010-11-17 | 1 | 2019-07-31 | View Edit Delete | ||||||||||||
| 673168 | 69383 | ANASTROZOL PENSA 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANASTROZOL PENSA 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69383/69383_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69383/69383_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2007-11-05 | 1 | 1 | 1 | 2007-11-05 | 2011-07-15 | 1 | 2011-09-22 | 660091 | View Edit Delete | |||||||||||
| 673289 | 73609 | SILDENAFILO PENSA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SILDENAFILO PENSA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 4 comprimidos | 50 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73609/73609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73609/73609_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2011-03-11 | 1 | 1 | 1 | 2011-03-11 | 2011-03-11 | 1 | 2015-05-20 | View Edit Delete | ||||||||||||
| 673291 | 73609 | SILDENAFILO PENSA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SILDENAFILO PENSA 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 8 comprimidos | 50 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73609/73609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73609/73609_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2011-03-11 | 1 | 1 | 1 | 2011-03-11 | 2011-03-11 | 1 | 2015-05-20 | View Edit Delete | ||||||||||||
| 673292 | 73610 | SILDENAFILO PENSA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SILDENAFILO PENSA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 4 comprimidos | 100 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73610/73610_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73610/73610_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2011-03-11 | 1 | 1 | 1 | 2011-03-11 | 2011-03-11 | 1 | 2015-05-20 | View Edit Delete | ||||||||||||
| 673294 | 73610 | SILDENAFILO PENSA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SILDENAFILO PENSA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 8 comprimidos | 100 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73610/73610_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73610/73610_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2011-03-11 | 1 | 1 | 1 | 2011-03-11 | 2011-03-11 | 1 | 2015-05-20 | View Edit Delete | ||||||||||||
| 672418 | 72690 | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 200 ml (vidrio) | 3,54 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml (vidrio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72690/72690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72690/72690_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2010-09-02 | 1 | 1 | 1 | 2010-09-02 | 2010-09-02 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 672419 | 72690 | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 120 ml (vidrio) | 3,54 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml (vidrio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72690/72690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72690/72690_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2010-09-02 | 1 | 1 | 1 | 2010-09-02 | 2010-09-02 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 672975 | 49417 | SENIORAL JARABE NIÑOS | SENIORAL JARABE NIÑOS, 1 frasco de 150 ml | 2,25 mg/15 ml + 19,5 mg/15 ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49417/49417_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49417/49417_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1971-07-01 | 1 | 1 | 1 | 1971-07-01 | 2011-05-16 | 1 | 2011-09-09 | 699256 | View Edit Delete | |||||||||||
| 674598 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 65 ml | 1 mmol/ml | 6 | 1 | 34 | 1 vial de 65 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 672220 | 61499 | PLASBUMIN 20% solución para perfusión | PLASBUMIN 20% solución para perfusión, 1 frasco de 100 ml | 200 g/L inyectable perfusión 100 ml | 6 | 1 | 48 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61499/61499_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61499/61499_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | INSTITUTO GRIFOLS S.A. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 2020-05-25 | 1 | 2023-10-16 | View Edit Delete | ||||||||||||
| 672238 | 61499 | PLASBUMIN 20% solución para perfusión | PLASBUMIN 20% solución para perfusión, 1 frasco de 50 ml | 200 g/L inyectable perfusión 50 ml | 6 | 1 | 48 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61499/61499_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61499/61499_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | INSTITUTO GRIFOLS S.A. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2018-10-29 | View Edit Delete | ||||||||||||
| 673046 | 61461 | NASOLINA 0,57 MG/ML SOLUCIÓN PARA PULVERIZACIÓN NASAL | NASOLINA 0,57 MG/ML SOLUCIÓN PARA PULVERIZACIÓN NASAL, 1 envase pulverizador de 20 ml | 0,5 mg/ml | 6 | 20 | 26 | 1 envase pulverizador de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61461/61461_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61461/61461_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 1997-03-01 | 1 | 1 | 1 | 1997-03-01 | 1997-05-01 | 1 | 2011-07-04 | View Edit Delete |
Page 262 of 1035, showing 20 records out of 20689 total, starting on record 5221, ending on 5240